<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30353228</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>24</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1433-7339</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>23</Day>                    </PubDate>                </JournalIssue>                <Title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</Title>                <ISOAbbreviation>Support Care Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00520-018-4501-x</ELocationID>            <Abstract>                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The reporting of osteonecrosis of the jaw (ONJ) related to anticancer agents without known antiresorptive properties (non-antiresorptives), such as antiangiogenics, tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors, immune checkpoint inhibitors, and cytotoxic chemotherapy is increasing.</AbstractText>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To review characteristics of ONJ in cancer patients receiving non-antiresorptives.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of the literature between 2009 and 2017 was conducted by the Bone Study Group of MASCC/ISOO.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 6249 articles reviewed and from personal communication, 42 ONJ cases related to non-antiresorptives were identified. No gender predilection was noted. Median age was 60 years and ONJ stage 2 was most common, with predilection for posterior mandible. Exposed bone, pain, and infection were common at diagnosis. In comparison to bone targeting agents (BTAs), radiology, histology, and management were similar, with medication often discontinued. Delayed diagnosis (median 8 weeks) was noted. Important differences included earlier time to ONJ onset (median 20 weeks), absence of trigger event (40%), and greater likelihood of healing and shorter healing time (median 8 weeks) as compared to BTA-related ONJ. Gastrointestinal cancers predominated, followed by renal cell carcinomas compared to breast, followed by prostate cancers in BTA-related ONJ, reflecting different medications.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Data about non-antiresorptive-related ONJ is sparse. This type of ONJ may have better prognosis compared to the BTA-related ONJ, suggested by greater likelihood of healing and shorter healing time. However, the delay in diagnosis highlights the need for more education. This is the first attempt to characterize ONJ associated with different non-antiresorptives, including BRAF and immune checkpoint inhibitors.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Nicolatou-Galitis</LastName>                    <ForeName>Ourania</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>Dental School, National and Kapodistrian University of Athens, Bouboulinas 41, N. Psyhico, 154 51, Athens, Greece. nicolatou.galitis@hotmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kouri</LastName>                    <ForeName>Maria</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Dental School, National and Kapodistrian University of Athens, Bouboulinas 41, N. Psyhico, 154 51, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Papadopoulou</LastName>                    <ForeName>Erofili</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Dental School, National and Kapodistrian University of Athens, Bouboulinas 41, N. Psyhico, 154 51, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vardas</LastName>                    <ForeName>Emmanouil</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Dental School, National and Kapodistrian University of Athens, Bouboulinas 41, N. Psyhico, 154 51, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Galiti</LastName>                    <ForeName>Dimitra</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Dental School, National and Kapodistrian University of Athens, Bouboulinas 41, N. Psyhico, 154 51, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Epstein</LastName>                    <ForeName>Joel B</ForeName>                    <Initials>JB</Initials>                    <AffiliationInfo>                        <Affiliation>Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Health System, Los Angeles CA and City of Hope National Medical Center, Duarte, CA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Elad</LastName>                    <ForeName>Sharon</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Campisi</LastName>                    <ForeName>Giuseppina</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Sector of Oral Medicine &quot;V. Margiotta&quot;, Department Di.Chir.On.S, University of Palermo, Palermo, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tsoukalas</LastName>                    <ForeName>Nikolaos</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Consultant Medical Oncologist, Oncology Department, Veterans Hospital (NIMTS), Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bektas-Kayhan</LastName>                    <ForeName>Kivanc</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Istanbul University, Istanbul, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tan</LastName>                    <ForeName>Winston</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Hematology/Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Body</LastName>                    <ForeName>Jean-Jacques</ForeName>                    <Initials>JJ</Initials>                    <AffiliationInfo>                        <Affiliation>CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Migliorati</LastName>                    <ForeName>Cesar</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lalla</LastName>                    <ForeName>Rajesh V</ForeName>                    <Initials>RV</Initials>                    <AffiliationInfo>                        <Affiliation>Section of Oral Medicine, University of Connecticut School of Dental Medicine, Farmington, CT, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <CollectiveName>MASCC Bone Study Group</CollectiveName>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>23</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Germany</Country>            <MedlineTA>Support Care Cancer</MedlineTA>            <NlmUniqueID>9302957</NlmUniqueID>            <ISSNLinking>0941-4355</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">BRAF inhibitors</Keyword>            <Keyword MajorTopicYN="N">Bone resorption</Keyword>            <Keyword MajorTopicYN="N">Cytotoxic chemotherapy</Keyword>            <Keyword MajorTopicYN="N">Immune checkpoint inhibitors</Keyword>            <Keyword MajorTopicYN="N">Inhibitors of angiogenesis</Keyword>            <Keyword MajorTopicYN="N">Osteonecrosis of the jaw</Keyword>            <Keyword MajorTopicYN="N">Tyrosine kinase inhibitors</Keyword>            <Keyword MajorTopicYN="N">mTOR inhibitors</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30353228</ArticleId>            <ArticleId IdType="doi">10.1007/s00520-018-4501-x</ArticleId>            <ArticleId IdType="pii">10.1007/s00520-018-4501-x</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>